Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (14,090) Arrow Down
Filter Results: (14,090) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (14,090)
    • People  (30)
    • News  (3,255)
    • Research  (9,144)
    • Events  (63)
    • Multimedia  (285)
  • Faculty Publications  (7,406)

Show Results For

  • All HBS Web  (14,090)
    • People  (30)
    • News  (3,255)
    • Research  (9,144)
    • Events  (63)
    • Multimedia  (285)
  • Faculty Publications  (7,406)
← Page 443 of 14,090 Results →
  • 31 Mar 2009
  • First Look

First Look: March 31, 2009

and Sugata Roychowdhury Abstract We examine the accrual choices of outsourcing firms with links to U.S. congressional candidates during the 2004 elections, when corporate outsourcing was a major campaign issue. We find that View Details
Keywords: Martha Lagace
  • 21 Jul 2014
  • Research & Ideas

Is a Gap in Small-Business Credit Holding Back the American Economy?

patents per employee than larger firms, and employ more than 40 percent of high-tech workers in America. “Small business owners feel that despite being creditworthy today, banks remain either wary or entirely unwilling to lend to them.”... View Details
Keywords: by Karen Mills; Manufacturing
  • November 2008 (Revised July 2009)
  • Background Note

A Managerial Perspective on Clinical Trials

By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)
  • 04 Jun 2013
  • First Look

First Look: June 4

note develops two hypotheses as to the impact of corporate political engagement: (i) a vehicle to facilitate good government and (ii) an instrument of special-interest capture.... View Details
Keywords: Sean Silverthorne
  • September 1986
  • Article

A Taxed-Based Test for Nominal Rigidities

By: J. J. Rotemberg, James Poterba and Lawrence Summers
Keywords: Taxation
Citation
Find at Harvard
Read Now
Related
Rotemberg, J. J., James Poterba, and Lawrence Summers. "A Taxed-Based Test for Nominal Rigidities." American Economic Review 76, no. 4 (September 1986): 659–675.
  • 2012
  • Chapter

Integrated Reporting Requires Integrated Assurance

By: Robert G. Eccles, Michael P. Krzus and Liv A. Watson
In the wake of the recent financial crisis, increasing the effectiveness of auditing has weighed heavily on the minds of those responsible for governance. When a business is profitable and paying healthy dividends to its stockholders, fraudulent activities and... View Details
Keywords: Risk Management; Crime and Corruption; Integrated Corporate Reporting; Governance Compliance; Organizational Culture; Management Systems; Laws and Statutes; Information Management; Accounting Audits; Financial Crisis
Citation
Related
Eccles, Robert G., Michael P. Krzus, and Liv A. Watson. "Integrated Reporting Requires Integrated Assurance." In Effective Auditing for Corporates: Key Developments in Practice and Procedures, edited by Joe Oringel, 161–178. London: Bloomsbury Information Ltd., 2012.
  • November 2024
  • Case

Ather Energy: The Future of Mobility

By: Shunyuan Zhang, Kannan Srinivasan and Malini Sen
Ather Energy, India’s third-largest electric scooter maker by volume, was founded in 2013. Five years later, the start-up launched its first electric scooter, Ather 450, which was powered by artificial intelligence (AI) and the Internet of Things (IoT), to navigate... View Details
Keywords: Energy Policy; Climate Change; Alternative Energy; Corporate Entrepreneurship; Transportation; Transformation; Green Technology; Technology Adoption; Communication Strategy; Marketing Strategy; Customer Focus and Relationships; Business Startups; Growth and Development Strategy; Brands and Branding; Product Launch; Product Positioning; Business Strategy; Segmentation; Asia; India
Citation
Educators
Purchase
Related
Zhang, Shunyuan, Kannan Srinivasan, and Malini Sen. "Ather Energy: The Future of Mobility." Harvard Business School Case 525-040, November 2024.
  • Article

Creating Firm Disclosures

By: Amir Amel-Zadeh, Alexandra Scherf and Eugene F. Soltes
Managers expend significant time and effort preparing disclosures about firm performance and strategy. Although prior literature has explored how variation in the style and presentation of disclosures impacts investors' perceptions of firms, little is known about how... View Details
Keywords: Disclosure; Earnings Conference Call; Field Study; MD&A; Textual Analysis; Corporate Disclosure
Citation
Find at Harvard
Register to Read
Related
Amel-Zadeh, Amir, Alexandra Scherf, and Eugene F. Soltes. "Creating Firm Disclosures." Journal of Financial Reporting 4, no. 2 (Fall 2019): 1–31.
  • 29 May 2014
  • Research & Ideas

Research Symposium 2014

and specialized interest in a political issue, and face little political opposition in the process. "In any given issue, there's a handful of... View Details
Keywords: by Carmen Nobel; Accounting; Health
  • June 2007 (Revised July 2008)
  • Case

Kinder Morgan, Inc. - Management Buyout

Kinder Morgan, Inc., was a leader in the transportation and distribution of energy throughout North America, managing a master limited partnership with over $35 billion in infrastructure assets. In the summer of 2006, Richard Kinder, the founder and chairman of Kinder... View Details
Keywords: Leveraged Buyouts; Fairness; Governing and Advisory Boards; Privatization; Partners and Partnerships; Conflict of Interests; North America
Citation
Educators
Purchase
Related
El-Hage, Nabil N., Leslie Pierson, Ewa Bierbrauer, and Francine Chew. "Kinder Morgan, Inc. - Management Buyout." Harvard Business School Case 207-123, June 2007. (Revised July 2008.)
  • 2007
  • Report

The Role of Clusters in the Chemical Industry

By: Christian H.M. Ketels
The European Chemical Industry, still in the leading position globally, is under intense competitive pressure from emerging locations in Asia and the Middle East. After first reacting by efficiency upgrading within companies and then pursuing outsourcing and aggressive... View Details
Keywords: Trade; Governing Rules, Regulations, and Reforms; Industry Clusters; Business and Government Relations; Competitive Strategy; Chemical Industry; Asia; Europe; Middle East
Citation
Read Now
Related
Ketels, Christian H.M. "The Role of Clusters in the Chemical Industry." Report, 2007. (Prepared for the Annual Conference of the European Petrochemical Association (EPCA))
  • 09 Nov 2010
  • First Look

First Look: November 9, 2010

multilateralism in the European Union. The renaissance of the Russian state and the rise of Gazprom, Russia's natural gas monopoly, have produced patterns of international politics that seemed almost... View Details
Keywords: Sean Silverthorne
  • January 2016 (Revised January 2019)
  • Case

The Allergan Board Under Fire (A)

By: Lynn S. Paine, Suraj Srinivasan, John C. Coates and David Lane
In 2014, the Allergan Inc. board of directors received a surprise takeover offer from Valeant Pharmaceuticals in alliance with hedge fund activist Bill Ackman's Pershing Square Capital Management. In the unprecedented arrangement between an acquirer and a hedge fund... View Details
Keywords: Allergan, Inc.; Valeant; Ackman; Pershing Square; Tender Offer; Activist Investors; Business Models; R&D; Board Of Directors; Securities Litigation; Acquisition Strategy; Takeover Defenses; Hedge Funds; Shareholder Rights; Proxy Contest; Shareholder Special Meetings; Legal Issues In Contested Takeovers; Governing and Advisory Boards; Mergers and Acquisitions; Corporate Governance; Management Teams; Business and Shareholder Relations; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Paine, Lynn S., Suraj Srinivasan, John C. Coates, and David Lane. "The Allergan Board Under Fire (A)." Harvard Business School Case 316-010, January 2016. (Revised January 2019.)
  • 22 Mar 2016
  • First Look

March 22, 2016

role of specific economic and political institutions in shaping the business environment and economic growth in emerging markets. It gives answers to the following questions:... View Details
Keywords: Sean Silverthorne
  • September–October 2024
  • Article

Boards Need a New Approach to Technology

By: Tarun Khanna, Mary C. Beckerle and Nabil Y. Sakkab
The boards of too many publicly traded companies are downright timid when considering matters involving science and technology. More often than not, they focus on security and digitization—a defensive posture that fails to consider the bigger opportunities emerging... View Details
Keywords: Governing and Advisory Boards; Opportunities; Technology Adoption
Citation
Find at Harvard
Register to Read
Related
Khanna, Tarun, Mary C. Beckerle, and Nabil Y. Sakkab. "Boards Need a New Approach to Technology." Harvard Business Review 102, no. 5 (September–October 2024): 128–137.
  • April 24, 2024
  • Editorial

Absolute Presidential Immunity Threatens National Security

By: Louis Caldera, George W. Casey Jr., Thad Allen, Deborah Lee James, Carlton Fulford, Craig McKinley, Sean O'Keefe and John Jumper
Keywords: Government Administration; Lawfulness; National Security
Citation
Register to Read
Related
Caldera, Louis, George W. Casey Jr., Thad Allen, Deborah Lee James, Carlton Fulford, Craig McKinley, Sean O'Keefe, and John Jumper. "Absolute Presidential Immunity Threatens National Security." Stars and Stripes (April 24, 2024).
  • March 2015 (Revised February 2017)
  • Case

Shanghai: GDP Apostasy

By: George Serafeim
Balancing economic growth alongside environmental sustainability and social inclusion was becoming increasingly important in China. The case describes Shanghai's decision to abandon growth of Gross Domestic Product (GDP) as its primary metric of measuring success.... View Details
Keywords: China; Gdp; Measurement; Measurement Problems; Accountability; Sustainability; Sustainable Development; Strategy Execution; Strategy; Balanced Scorecard; Strategy Map; Macroeconomics; Measurement and Metrics; Corporate Accountability; Accounting; Environmental Sustainability; Development Economics; Corporate Governance; Shanghai
Citation
Educators
Purchase
Related
Serafeim, George, Rebecca Henderson, and David Freiberg. "Shanghai: GDP Apostasy." Harvard Business School Case 115-042, March 2015. (Revised February 2017.)
  • 21 Jan 2011
  • News

A Blueprint for Keeping America Competitive

Keywords: Executive, Legislative, and Other General Government Support; Executive, Legislative, and Other General Government Support
  • 2022
  • Working Paper

Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

By: Amitabh Chandra, Jennifer Kao, Kathleen Miller and Ariel D. Stern
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA’s Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to... View Details
Keywords: Research and Development; Governing Rules, Regulations, and Reforms; Product Development
Citation
Find at Harvard
Purchase
Related
Chandra, Amitabh, Jennifer Kao, Kathleen Miller, and Ariel D. Stern. "Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation." NBER Working Paper Series, No. 30712, December 2022.
  • 02 Feb 2021
  • Blog Post

Finding My Focus in Health care Amidst a Global Pandemic

biotechnology and health-tech companies. After about a year and a half, I went to work at one of JPM’s clients to build their Growth Strategy team. After an interesting first several months, I found myself... View Details
  • ←
  • 443
  • 444
  • …
  • 704
  • 705
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.